
In yet another setback for the future of HIV prevention, the only HIV vaccine in a late-stage trial has failed, study leaders announced Wednesday. Launched in 2019 as a partnership between the U.S. government and the pharmaceutical giant Janssen, the Mosaico trial was being conducted in eight European nations and the Americas, including the United… read on > read on >